Yaws Clinical Trial - Evaluation of a LAMP Assay for T. Pallidum. Pertenue

Updated 04/23/2024

Status Active, not recruiting

Clinical Trial Summary

This is a diagnostic evaluation comparing the performance of real-time PCR performed at a national reference laboratory and a LAMP assay performed at a regional hospital for the diagnosis of yaws

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Yaws

Clinical Trial Details

NCT number	NCT04753788
Study type	Observational
Source	London School of Hygiene and Tropical Medicine
Contact
Status	Active, not recruiting
Phase
Start date	March 15, 2021
Completion date	May 2024

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01382004` - Single-dose Azithromycin for the Treatment of Yaws	Phase 3
	Completed	`NCT03664063` - PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )	Phase 2
	Completed	`NCT03676140` - Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )	Phase 3
	Completed	`NCT04453124` - An Accessible Low-cost Plant Treatment for Cutaneous Ulcers	Phase 2
	Completed	`NCT01955252` - Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea	Phase 3
	Recruiting	`NCT05764876` - Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)	Phase 3
	Completed	`NCT02344628` - Comparison of Two Different Doses of Azithromycin for Treatment of Yaws	Phase 3
	Recruiting	`NCT03683745` - Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
	Completed	`NCT02775617` - Azithromycin - Ivermectin Mass Drug Administration for Skin Disease	Phase 4
	Completed	`NCT01841203` - Dual Point-of-care Test for the Diagnosis of Yaws	N/A
	Completed	`NCT03490123` - Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication	Phase 4